US says first swine flu vaccine to arrive Oct. 5

Sep 25, 2009

(AP) -- The first swine flu vaccine should be in some doctors' offices as early as Oct. 5, U.S. health officials said Friday.

These early batches of vaccine will protect 6 million to 7 million people. Over time, the government expects to have a total of 250 million doses of the new vaccine, although 10 percent of that has been promised to other countries.

The U.S. vaccine shipments will go directly to doctors, clinics and other providers designated by each state, Centers for Disease Control and Prevention officials said at a press conference. Most of the initial doses will be a nasal spray form of vaccine, but the majority of doses during flu season will be shots.

CDC officials also said swine flu is widespread in 26 states now, up from 21 a week ago.

Some possible good news - the intensity is trending down a little in the Southeast. The percentage of doctor's office visits for flu-like illnesses fell slightly in Georgia and some other states. However, the improvement is only slight and it's not clear if it's the start of a national trend or not, CDC officials said.

The CDC doesn't have an exact count of swine flu deaths and hospitalizations, but existing reports suggest the infection has caused more than 600 deaths and more than 9,000 hospitalizations.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: EU regulator: Morning-after pill OK for all women

add to favorites email to friend print save as pdf

Related Stories

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

Panel urges some swine flu vaccine next month

Aug 24, 2009

(AP) -- The government should speed availability of at least a little swine flu vaccine next month instead of in October, the president's scientific advisers recommended Monday.

Recommended for you

EU regulator: Morning-after pill OK for all women

7 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

11 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

12 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments : 0